Related Experiment Video
Updated: Sep 11, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Feasibility of an Intravenous Home Chemotherapy Intervention With Low-Dose Cytarabine Administered by Parents
Louise Ingerslev Roug1, Lisa Lyngsie Hjalgrim1, Tenna Ruest Haarmark Nielsen1
1Department of Pediatric and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Background:
Intravenous home chemotherapy (IHC) can reduce the frequency of hospital visits and positively affect the child's and the family's everyday life. Knowledge about IHC is needed to enhance evidence-based provision and implementation. This study aimed to evaluate the feasibility of an IHC intervention.
Procedure:
Single-arm feasibility study including children aged 1-17 years diagnosed with leukemia or lymphoma and their parents. The intervention consisted of an education program designed to enable parents to administer intravenous low-dose cytarabine at home. Feasibility outcomes were families' demand for the intervention, acceptability (satisfaction, preference, and caregiver demand), and safety. Data were collected from medical records, clinical registrations, and questionnaires and analyzed using descriptive statistics.
Results:
Of the 17 children meeting the key inclusion criteria (mean age 5.1, range 2-15), 15 were enrolled. These children received a total of 175 low-dose cytarabine administrations at home, constituting 56% of the planned doses. The continued home administration of cytarabine suggests sustained acceptability. Parents expressed high satisfaction with home administration and indicated a preference for it in future treatments. Caregiver demand scores showed no indication of increased caregiver demand during the IHC intervention. No severe adverse events were observed.
Conclusions:
The IHC intervention is a feasible, acceptable, and safe option in this specific context, allowing children to receive intravenous chemotherapy administered by their parent in the comfort of their home.
Related Concept Videos
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Factors Affecting Drug Response: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

